Barclays’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.04M Sell
411,523
-34,134
-8% -$584K ﹤0.01% 1367
2025
Q1
$28.4M Sell
445,657
-44,380
-9% -$2.83M 0.01% 636
2024
Q4
$59.6M Buy
490,037
+30,137
+7% +$3.66M 0.02% 420
2024
Q3
$57.4M Buy
459,900
+59,002
+15% +$7.37M 0.02% 469
2024
Q2
$63.3M Buy
400,898
+15,418
+4% +$2.44M 0.02% 431
2024
Q1
$49.9M Sell
385,480
-57,426
-13% -$7.43M 0.02% 504
2023
Q4
$42.7M Sell
442,906
-74,380
-14% -$7.17M 0.02% 548
2023
Q3
$62.7M Buy
517,286
+118,761
+30% +$14.4M 0.04% 395
2023
Q2
$45.6M Sell
398,525
-55,085
-12% -$6.31M 0.03% 466
2023
Q1
$62.5M Buy
453,610
+38,602
+9% +$5.32M 0.03% 274
2022
Q4
$53.8M Buy
415,008
+136,542
+49% +$17.7M 0.02% 342
2022
Q3
$30.8M Buy
278,466
+68,496
+33% +$7.57M 0.03% 450
2022
Q2
$15.7M Buy
209,970
+157,498
+300% +$11.8M 0.01% 667
2022
Q1
$4.1M Sell
52,472
-3,791
-7% -$296K ﹤0.01% 1286
2021
Q4
$5.06M Buy
56,263
+1,083
+2% +$97.5K ﹤0.01% 1232
2021
Q3
$5.1M Buy
55,180
+36,786
+200% +$3.4M ﹤0.01% 1249
2021
Q2
$1.43M Sell
18,394
-35,492
-66% -$2.76M ﹤0.01% 1915
2021
Q1
$4.02M Buy
53,886
+223
+0.4% +$16.6K ﹤0.01% 1354
2020
Q4
$9.15M Sell
53,663
-17,522
-25% -$2.99M ﹤0.01% 797
2020
Q3
$10M Sell
71,185
-106
-0.1% -$14.9K 0.01% 726
2020
Q2
$11.4M Sell
71,291
-51,498
-42% -$8.26M 0.01% 606
2020
Q1
$12M Sell
122,789
-55,791
-31% -$5.46M 0.01% 557
2019
Q4
$23M Buy
178,580
+128,999
+260% +$16.6M 0.01% 573
2019
Q3
$3.73M Sell
49,581
-4,341
-8% -$327K ﹤0.01% 1272
2019
Q2
$8.19M Sell
53,922
-2,349
-4% -$357K 0.01% 906
2019
Q1
$6.71M Buy
56,271
+19,887
+55% +$2.37M ﹤0.01% 881
2018
Q4
$3.97M Sell
36,384
-7,916
-18% -$864K ﹤0.01% 1018
2018
Q3
$7.16M Sell
44,300
-117,809
-73% -$19M 0.01% 883
2018
Q2
$21.4M Buy
162,109
+116,470
+255% +$15.4M 0.02% 478
2018
Q1
$3.38M Sell
45,639
-96,763
-68% -$7.17M ﹤0.01% 1077
2017
Q4
$7.92M Sell
142,402
-136,740
-49% -$7.61M 0.01% 727
2017
Q3
$12.7M Buy
279,142
+244,913
+716% +$11.1M 0.01% 499
2017
Q2
$1.15M Sell
34,229
-61,590
-64% -$2.07M ﹤0.01% 1482
2017
Q1
$2.84M Buy
95,819
+16,109
+20% +$477K ﹤0.01% 1014
2016
Q4
$2.19M Buy
79,710
+64,192
+414% +$1.76M ﹤0.01% 1107
2016
Q3
$952K Sell
15,518
-191,792
-93% -$11.8M ﹤0.01% 1442
2016
Q2
$3.95M Buy
207,310
+198,661
+2,297% +$3.79M 0.01% 827
2016
Q1
$164K Buy
8,649
+8,198
+1,818% +$155K ﹤0.01% 2140
2015
Q4
$17K Sell
451
-49,393
-99% -$1.86M ﹤0.01% 2729
2015
Q3
$1.6M Buy
49,844
+48,975
+5,636% +$1.57M ﹤0.01% 1201
2015
Q2
$27K Sell
869
-1,286
-60% -$40K ﹤0.01% 2849
2015
Q1
$28K Sell
2,155
-1,762
-45% -$22.9K ﹤0.01% 2986
2014
Q4
$54K Sell
3,917
-1,288
-25% -$17.8K ﹤0.01% 2980
2014
Q3
$109K Sell
5,205
-895
-15% -$18.7K ﹤0.01% 2597
2014
Q2
$177K Sell
6,100
-38,043
-86% -$1.1M ﹤0.01% 2448
2014
Q1
$1.06M Sell
44,143
-232,660
-84% -$5.58M ﹤0.01% 1639
2013
Q4
$5.54M Buy
276,803
+76,241
+38% +$1.52M 0.01% 963
2013
Q3
$9.43M Sell
200,562
-246,654
-55% -$11.6M 0.01% 635
2013
Q2
$17M Buy
+447,216
New +$17M 0.02% 377